Hüser L - Search Results

1

Novak D, Hüser L, Elton JJ, Umansky V, Altevogt P, Utikal J. Novak D, et al. Among authors: huser l. Semin Cancer Biol. 2020 Dec;67(Pt 1):74-82. doi: 10.1016/j.semcancer.2019.08.007. Epub 2019 Aug 11. Semin Cancer Biol. 2020. PMID: 31412296 Free article. Review.

2

TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells.

Weina K, Wu H, Knappe N, Orouji E, Novak D, Bernhardt M, Hüser L, Larribère L, Umansky V, Gebhardt C, Utikal J. Weina K, et al. Among authors: huser l. Pigment Cell Melanoma Res. 2016 Jul;29(4):453-8. doi: 10.1111/pcmr.12483. Pigment Cell Melanoma Res. 2016. PMID: 27105574

3

New role of ID3 in melanoma adaptive drug-resistance.

Sachindra, Larribère L, Novak D, Wu H, Hüser L, Granados K, Orouji E, Utikal J. Sachindra, et al. Among authors: huser l. Oncotarget. 2017 Nov 27;8(66):110166-110175. doi: 10.18632/oncotarget.22698. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299138 Free PMC article.

4

SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma.

Hüser L, Sachindra S, Granados K, Federico A, Larribère L, Novak D, Umansky V, Altevogt P, Utikal J. Hüser L, et al. Int J Cancer. 2018 Dec 15;143(12):3131-3142. doi: 10.1002/ijc.31609. Epub 2018 Oct 16. Int J Cancer. 2018. PMID: 29905375 Free article.

5

Targeting SOX2 in anticancer therapy.

Hüser L, Novak D, Umansky V, Altevogt P, Utikal J. Hüser L, et al. Expert Opin Ther Targets. 2018 Dec;22(12):983-991. doi: 10.1080/14728222.2018.1538359. Epub 2018 Oct 26. Expert Opin Ther Targets. 2018. PMID: 30366514 Review.

6

Targeted Therapy-Resistant Melanoma Cells Acquire Transcriptomic Similarities with Human Melanoblasts.

Larribère L, Kuphal S, Sachpekidis C; Sachindra; Hüser L, Bosserhoff A, Utikal J. Larribère L, et al. Among authors: huser l. Cancers (Basel). 2018 Nov 16;10(11):451. doi: 10.3390/cancers10110451. Cancers (Basel). 2018. PMID: 30453548 Free PMC article.

7

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies.

Hüser L, Altevogt P, Utikal J. Hüser L, et al. Oncotarget. 2019 Mar 1;10(18):1662-1663. doi: 10.18632/oncotarget.26718. eCollection 2019 Mar 1. Oncotarget. 2019. PMID: 30899437 Free PMC article. No abstract available.

8

Histone methyltransferase SETDB1 contributes to melanoma tumorigenesis and serves as a new potential therapeutic target.

Orouji E, Federico A, Larribère L, Novak D, Lipka DB, Assenov Y, Sachindra S, Hüser L, Granados K, Gebhardt C, Plass C, Umansky V, Utikal J. Orouji E, et al. Among authors: huser l. Int J Cancer. 2019 Dec 15;145(12):3462-3477. doi: 10.1002/ijc.32432. Epub 2019 Jun 9. Int J Cancer. 2019. PMID: 31131878 Free article.

9

Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling.

Fleming V, Hu X, Weller C, Weber R, Groth C, Riester Z, Hüser L, Sun Q, Nagibin V, Kirschning C, Bronte V, Utikal J, Altevogt P, Umansky V. Fleming V, et al. Among authors: huser l. Cancer Res. 2019 Sep 15;79(18):4715-4728. doi: 10.1158/0008-5472.CAN-19-0053. Epub 2019 Jul 23. Cancer Res. 2019. PMID: 31337655

10

T-type calcium channel inhibition restores sensitivity to MAPK inhibitors in de-differentiated and adaptive melanoma cells.

Granados K, Hüser L, Federico A, Sachindra S, Wolff G, Hielscher T, Novak D, Madrigal-Gamboa V, Sun Q, Vierthaler M, Larribère L, Umansky V, Utikal J. Granados K, et al. Among authors: huser l. Br J Cancer. 2020 Mar;122(7):1023-1036. doi: 10.1038/s41416-020-0751-8. Epub 2020 Feb 17. Br J Cancer. 2020. PMID: 32063604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page